Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

Supplemental Figure S1 from Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

<p>Supplemental Figure S1. Mean pharmacokinetic profiles for single agent talazoparib (BMN673 in phase I clinical trial PRP-001) versus combination therapy.</p>

Saved in:

書目詳細資料
主要作者:	Zev A. Wainberg (15047031) (author)
其他作者:	Arun S. Singh (15036660) (author), Gottfried E. Konecny (15047034) (author), Kelly E. McCann (15047037) (author), J. Randolph Hecht (15047040) (author), Jonathan Goldman (15047043) (author), Bartosz Chmielowski (15036666) (author), Richard S. Finn (10431048) (author), Neil O'Brien (15047046) (author), Erika Von Euw (15047049) (author), Megan M. Price (15047052) (author), Diego Martinez (15047055) (author), Lisa Yonemoto (15047058) (author), Meghan Brennan (15047061) (author), John A. Glaspy (15047064) (author), Dennis J. Slamon (15047067) (author)
出版:	2025
主題:	Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Clinical Trial Results Phase I clinical trials Drug Targets Oncoprotein & tumor suppressor drug targets Preclinical Models In vitro models of cancer
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

Cannot write session to /tmp/vufind_sessions/sess_ncg2cfrm7miq0n9etn2ppp3u2b